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Background: Rat mast cells were regarded as a good model 
for mast cell function in immune response. Methods: Rat 
bone marrow mast cells (BMMC) were prepared both by re-
combinant rat IL-3 (rrIL-3) and by recombinant mouse stem 
cell factor (rmSCF), and investigated for both proliferation 
and differentiation in time course. Rat BMMC was induced 
by culture of rat bone marrow cells (BMCs) in the presence 
of both rrIL-3 (5 ng/ml) and rmSCF (5 ng/ml). Culture media 
were changed 2 times per week with the cell number con-
dition of 5×10
4/ml in 6 well plate. Proliferation was analyzed 
by cell number and cell counting kit-8 (CCK-8) and differ-
entiation was by rat mast cell protease (RMCP) II and 
histamine. Results: Cell proliferation rates reached a max-
imum at 8 or 11 days of culture and decreased thereafter. 
However, both RMCP II production and histamine synthesis 
peaked after 11 days of culture. By real time RT-PCR, the 
level of histidine decarboxylase mRNA was more than 500 
times higher on culture day 11 than on culture day 5. By 
transmission electron microscopy, the cells were heteroge-
neous in size and contained cytoplasmic granules. Using gat-
ed flow cytometry, we showed that cultured BMCs ex-
pressed high levels of FcεRI and the mast cell antigen, gan-
glioside, on culture day 11. Conclusion: These results in-
dicate that rat BMMCs were generated by culturing BMCs 
in the presence of rrIL-3 and rmSCF and that the BMMCs 
have the characteristics of mucosal mast cells. 
[Immune Network 2010;10(1):15-25]
INTRODUCTION
Mast cells derived from bone marrow are important immune 
cells that control innate and adaptive immunity (1-3). These 
cells  are  heterogeneous,  depending  on  the  tissue  location, 
and  have  diverse  functions,  such  as  secretion  of  cytokine 
amines and prostaglandins as well as expression of cell mem-
brane proteins that activate adjacent cells (4-6). In addition, 
these cells produce heparin, which is not produced by any 
other  cells,  and  have  a  role  in  vasculogenesis  (7,8).
  The investigation of mast cell using mast cell line such as 
RBL-2H3,  or  HMC-1  has  contributed  the  comprehension  of 
cell activation and immune function of mast cells. However, 
for the application of cell therapy, the study of mast cell pre-
pared by primary cell culture was necessary. Generating mast 
cells from direct differentiation of proliferating bone marrow 
cells (BMC) provides an ample supply of mast cells. Rat bone 
marrow-derived  mast  cells  (BMMC)  were  first  generated  by 
Haig et al in 1982 using conditioned medium (CM) prepared 
from the cell culture supernatant of mesenteric lymph node 
cells. The lymph node cells were harvested from rats infected 
with Nipponstrongylus brasiliensis (9). In 1999, McCloskey et 
al described rat BMMC induction by both recombinant rat IL-3 
(rrIL-3) and recombinant human stem cell factor (rhSCF) and 
contributed the comprehension of minimal required cytokines 
for rat BMMC culture (10). Since then, no study has charac-
terized rat BMMCs generated with recombinant cytokines, nor 
have  there  been  any  reports  on  the  immune  function  of Rat Bone Marrow-derived Mast Cell Induction
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BMMCs,  as  assessed  by  a  pubmed  search.
    Mouse  BMMCs  induced  by  recombinant  mouse  IL-3  are 
widely  used  to  study  mast  cell  function  (11,12).  However, 
they are not appropriate for certain parasite infection models. 
The investigations using rat system produce the results con-
tributing to comprehension of human infection in Trichinella 
spiralis, Clonorchis sinensis and Anisakis simplex (13-15). In 
these instances, the rat is a better model. The preparation of 
rat BMMC with recombinant cytokines was reported by the 
research group of McCloskey et al, using cell culture super-
natant  of  COS  cells  transfected  with  necessary  plasmid 
(10,16).  However,  their  rat  BMMC  preparation  was  not 
known to be repeated by any other research laboratories. As 
the investigation of rat BMMC did not continue for 10 years, 
rat BMMC induction by recombinant cytokines was necessary 
for  replication  by  any  other  investigator.
    Mast  cells  have  the  characteristics  to  produce  histamine. 
Although histamine activate diverse immune cells, that causes 
itch sensation or anaphylaxis in certain situation (17,18). In 
rat BMMC preparation, although mast cell maturity was ana-
lyzed by rat mast cell protease (RMCP) II, histamine synthesis 
is a good indicator to comprehend mast cell differentiation. 
Therefore, we have characterized rat BMMCs generated from 
recombinant  cytokine  induction  of  BMCs  in  relation  with 
RM C P II  l ev e l a nd  h is ta mi ne  p ro du c ti on .  Th e  d es cr ib ed  r at 
BMMCs are expected to enhance studies of mast cell immune 
function.
MATERIALS AND METHODS
Animals
Seven-ten wk old female Sprague-Dawley outbred rats (150∼
200 g) were purchased from Samtako (Osan, South Korea). 
They were maintained in an experimental animal room and 
handled according to the guidelines of the Korean University 
Institutional  Animal  Care  and  Use  Committee.  All  studies 
were  performed  with  approval  from  the  committee.
Materials
Both  rrIL-3  and  rmSCF  were  purchased  from  Biosource 
International-Invitrogen  (Camarillo  CA,  USA)  or  from  R&D 
Systems  (Minneapolis  MN,  USA)  (19,20).  R  rat  IL-4  (rrIL-4) 
and r rat IL-6 (rrIL-6) were purchased from Biosource. LPS 
and Con A were purchased from Sigma (St. Louis MO, USA). 
B C 4 ,  m A b  t a r g e t i n g  r a t  h i g h  a f f i n i t y  I g E  r e c e p t o r  ( F cεRI), 
and AA4, mAb targeting rat mast cell antigen of ganglioside, 
were  purchased  from  BD  Biosciences  (Jan  Jose,  CA,  USA) 
(21,22).  PE-labeled  goat  anti-mouse  Ig-multiple  adsorbed 
(PEGAMM)  and  PE-conjugated  rat  anti-mouse  IgG1  mAb 
(PERAMG1) were also purchased from BD BioSciences. The 
RMCP  II  ELISA  kit  was  purchased  from  Moredun  Scientific 
limited (Midlothian, UK), and EIA HISTAMINE was purchased 
from Immunotech (Marseille, France) (23,24). The DC protein 
assay kit was purchased from Bio-Rad (Hercules, CA, USA). 
The prototype of rat IgE, IR162 was purchased from Zymed 
(San  Francisco,  CA,  USA).
BMC preparation and mast cell induction
Rats  were  euthanized  by  anesthetization  with  CO2 a n d  c e r-
vical dislocation. Bone marrow cells were harvested from the 
femur by syringe pumping and were separated from the red 
blood  cells  using  a  50%  or  70%  Percoll  gradient  cushion 
(25,26). Cells were then washed with incomplete IMDM, sup-
plemented with penicillin/streptomycin and gentamycin. Cells 
were plated at 5×10
4 cells/ml per well of a 6-well plate in 
complete IMDM supplemented with 20% inactivated horse se-
rum,  sodium  pyruvate,  2-ME,  non  essential  amino  acids, 
L-glutamine, HEPES, and antibiotics. Each well was filled with 
3  ml  culture  media  that  was  changed  2  times  per  week. 
W h e n  n e c e s s a r y ,  c e l l s  w e r e  c u l t u r e d  f o r  4  d a y s  w i t h o u t  
c h a n g i n g  t h e  m e d i u m .  C e l l  n u m b e r s  w e r e  c a l c u l a t e d  u s i n g  
a  hemocytometer.
Flow cytometry
Phenotypes  were  analyzed  by  flow  cytometry  using 
FACSCalibur (BD Biosciences, Jan Jose, CA, USA). Cell size 
was gated by FSC and SSC. Suspending cells were harvested 
f ro m c ul tu re  pla te  an d w ash e d w it h P BS  b y  c e nt ri fu g at io n. 
Cell suspensions were incubated with BC4, or AA4 mAb for 
30  minutes  on  ice.  Cells  were  washed  twice  with  ice  cold 
PBS and were incubated with PEGAMM or PERAMG1 for 1 
hour. Cells were washed 3 times and then analyzed by flow 
cytometry.
Analysis of RMCP II and histamine
RMCP  II  production or  histamine synthesis was used as  an 
indicator for rat mast cell differentiation. RMCP II and hista-
mine  levels  were  analyzed  using  the  RMCP  II  ELISA  kit 
(Moredun Scientific limited Midlothian, UK) (23) or the EIA 
HISTAMINE  (Immunotech,  Marseille,  France)  (24),  respec-
tively,  according  to  the  manufacturer’s  instruction.  For  the 
cells cultured in 6 well plate, cell lysate prepared with Triton Rat Bone Marrow-derived Mast Cell Induction
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X-100 were applied. For the cells cultured in 96 well plate, 
c e l l  a n d  c e l l  s u p e r n a t a n t  w e r e  a p p l i e d .
Proliferation and cell number
Cell proliferation was analyzed using the Cell counting kit-8 
(CCK-8, Dojindo Laboratories, Kumamoto, Japan). Harvested 
cells  were  plated  at  10
5  cells/well  of  a  96-well  cell  culture 
plate  and  were  cultured  at  37
oC  in  a  humidified  incubator 
with 5% CO2. Ten microliter CCK-8 diluted by ten times with 
IMDM was added to each well. After 4 hrs, the OD was read 
at  450  nm  using  a  Spectramax  ELISA  microplate  reader 
(Molecular  Devices,  Menlo  Park,  CA,  USA).  Cell  numbers 
were  calculated  using  a  hemocytometer  (purchased  from 
Sigma)  when  the  media  was  changed.
Mast cell exocytosis
Cells were harvested at culture day 8 and incubated (cell No. 
10
6/ml, 3 ml/well) in complete IMDM with IR162 (1μg/ml) 
(27) in the presence of 5 ng/ml rrIL-3 and 5 ng/ml rmSCF 
for 16 hrs at 37
oC in a CO2 incubator. Cells were washed once 
with  Tyrode’s  solution.  The  cell  supernatant  was  aspirated 
without disturbing the cell pellet. Cells were resuspended in 
Tyrode’s solution to 6.7×10
5 cells/ml and treated with 5μg/ml 
of the rat IgE-specific mAb, B5 (28). Each 4 ml polypropylene 
tube contained 200μl of cell suspension. β-hexosaminidase 
r e l e a s e d  f r o m  t h e  m a s t  c e l l s  w a s  a n a l y z e d  u s i n g  p-nitro-
pnenyl-N-acetyl-β-D-glucosaminide  as  a  substrate  (29,30).
Real time quantitative RT-PCR
RNA was extracted from harvested cells using Trizol (Gibco 
Division of Invitrogen, Carlsbad, CA, USA). cDNA was syn-
thesized by incubating RNA at 25
oC for 10 min, at 48
oC for 
30 min, and then at 95
oC for 5 min with the SUPERSCRIPT 
r e v e r s e  t r a n s c r i p t a s e  ( I n v i t r o g e n ,  C a r l s b a d ,  C A ,  U S A )  i n  a  
PTC-100  thermal  cycler  (MJ  Research,  Inc.  Watertown  MA, 
USA).  HDC  real  time  PCR  primers  included  the  following: 
sense, 5’-GCA GCA AGG AAG AAC AAA ATC C-3’; antisense, 
5’-CAA CAA GAC GAG CGT TCA GAG A-3’; probe, FAM-AAA 
GCG CAT GAG CCC AAT GCT GAT-TAMRA (31,32). These 
w e r e  p u r c h a s e d  f r o m  B i o n e e r  ( D a e d o c k g u ,  D a e j e o n  S o u t h  
Korea).  The  primers  and  probe  for  rodent  GAPDH  (Rat- 
GAPDH) were purchased from Applied Biosystems (Carlsbad, 
CA, USA) (33). The following PCR parameters were used: an 
initial incubation at 50
oC 2 min and a denaturation for 10 min 
at  95
oC,  followed  by  40  cycles  of  15  seconds  at  95
oC  and 
1  min  at  60
oC .  R e a l  t i m e  P C R  w a s  a s s a y e d  u s i n g  t h e  A B I  
Prism 7000 (Applied Biosystems). HDC mRNA expression lev-
els were normalized against rat GAPDH using a relative quan-
titation  of  gene  expression  2
−△△C
T ( 3 4 ) .
Transmission electron microscopy (TEM)
Harvested cells were fixed in a mixture of 2% glutaraldehyde 
and 2%paragormaldehyde. Cells were treated with 1% OsO4 
and processed for TEM by the Division of Particular instru-
ments and materials of the Medical Science Research Center 
(MSRC) at the Korean University College of Medicine (KUMC) 
(35).  The  prepared  samples  were  analyzed using  a  Hitachi 
H-7500  transmission  electron  microscope.
Toluidine blue staining
Cells were harvested and plated on lysine-coated glass slides. 
Cultured cells were fixed in 100% ethanol and dried. Fixed 
cells were stained with Toluidine blue O or with Leishman 
stain  (36,37).
Statistical analysis
Data were presented as mean±SE, when available. Statistical 
analyses  were  performed  using  Excel  (Microsoft).  Standard 
error  bars  (SE)  are  shown.
RESULTS
Light microscopic view of rat bone marrow cells
Rat bone marrow cells cultured in rrIL-3 and rmSCF were vi-
sualized by light microscopy. Day 5 cells (Fig. 1A) were di-
v e r s e  i n  s i z e  a n d  h a d  b l a s t  l i k e  s t r u c t u r e s  i n  c e l l  c l u s t e r s .  
When stained by Toluidine blue, 4-day cells (Fig. 1B), 11-day 
cells (Fig. 1C) and 18-day cells (Fig. 1D) had pinkish cyto-
plasmic  staining.
TEM view of rat bone marrow cell
To  understand  the  detailed  structure  of  cultured  cells,  cells 
were assayed by TEM. Rat bone marrow cells that were har-
vested over a 70% Percoll cushion on day 0 were very diverse 
in size and intracellular structure. The outer cell membrane 
was relatively irregular (Fig. 2A). At day 4, round cells with 
large nuclei were relatively predominant. Cells with dense cy-
toplasm,  as  seen  by  round  black  spots,  were  seen  inter-
m i t t e n t l y .  A t  d a y  1 1 ,  t h e  s i z e  o f  t h e  n u c l e i  w a s  r e l a t i v e l y  
s m a l l e r  t h a n  t h a t  o f  d a y  4  c e l l s .  T h e  a m o u n t  o f  c y t o p l a s m 
was greater at day 11 than that at day 4. At day 15, the cells 
with dense cytoplasm were rare, and open or empty cytoplas-Rat Bone Marrow-derived Mast Cell Induction
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Figure 1. Light microscopic view (A) and Toluidine blue staining (B∼D) of rat bone marrow cells. Cultured rat bone marrow cells were harvested
at (B) 4 days, (C) 11 days, or (D) 18 days and were stained by Toluidine blue.
mic  structures  were  observed.
Flow cytometric analysis of cultured rat bone marrow 
cells
Fig.  3  presents  the  flow  cytometric  analysis  of  cultured  rat 
bone  marrow  cells.  Cells  were  harvested  at  day  11. 
Population analysis by light scatter demonstrated two groups, 
which were gated as R1 and R2 (Fig. 3A). The constituents 
of R1 were negative for BC4 or AA4 staining (Fig. 3B, D). 
However, the most constituents of R2 were BC4 and AA4 pos-
i t i v e  a s  e v i d e n c e d  ( F i g .  3 C ,  E ) .
Proliferation and differentiation of cultured rat bone 
marrow cells
Rat bone marrow cells were cultured in a humidified CO2 in-
cubator at 37
oC in the presence of several concentrations of 
rrIL-3 and rmSCF. Five nanograms per milliliter both of rrIL-3 
and of rmSCF were selected as the concentration required to 
induce evident cell proliferation (data not shown). The effects 
of culture media, supplemental serum, and cell density were 
analyzed by comparing RPMI-1640 vs. IMDM, FBS vs horse 
serum  (HS),  and  50%  Percoll  vs.  70%  Percoll,  respectively. 
W h e n  c u l t u r e d  i n  I M D M  s u p p l e m e n t e d  w i t h  F B S ,  c e l l  p r o-
liferation peaked on culture day 8, regardless of cell differ-
entiation density (Fig. 4A, closed circle and close triangle). 
When  cultured  in  IMDM  supplemented  with  HS,  cell  pro-
liferation peaked on culture day 11 (Fig. 4A, open circle and 
open triangle). When cells were harvested over a 50% Percoll 
cushion and supplemented with HS supplement, proliferation 
peaked on day 8, regardless of the culture media used (Fig. 
4B, closed circle and closed triangle). In other conditions test-
ed, proliferation peaked on day 11 (Fig. 4B, open circle and 
open  triangle,  Fig.  4C).
    RMCP II production peaked on day 11, regardless of cell Rat Bone Marrow-derived Mast Cell Induction
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Figure 2. TEM of rat bone marrow 
cells. Rat bone marrow cells 
cultured in the presence of rrIL-3 
and rmSCF were analyzed by TEM 
at day 0 (A), day 4 (B), day 11 (C), 
and day 15 (D).
proliferation  (Fig.  4D∼F).  Histamine  synthesis  peaked  on 
culture  day  11  (Fig.  4G∼I).
Exocytosis of rat BMMCs by rat IgE and monoclonal 
anti rat IgE
Exocytosis of prepared rat BMMC was induced by the rat IgE, 
IR162, and the anti rat IgE, B5. The level of exocytosis was 
approximately 20% of the total cell lysate (Fig. 5). The total 
cell  lysate  was  prepared  by  lysing  cells  in  1%  TritonX- 
100/Tyrode. The exocytosis of rat BMMC induced by rat IgE 
and anti rat IgE showed a dose relationship when multiple 
number  of  rat  BMMC  was  applied  (data  not  shown).
Effects of IL-4, IL-6, LPS, and Con A on activated 
bone marrow cells
On the culture day 8, cells were cultured with a diverse com-
bination  of  several  cell  activators,  including  rmIL-3,  rrIL-4, 
r r I L - 6 ,  L P S ,  a n d  C o n A  ( F i g .  6 ,  b o t t o m  t a b l e ) .  A s  m e a s u r e d 
w it h  t he  c e ll co u nt in g  k it ,  CC K -8 ,  c e lls  c ul tu re d  w it h rrI L- 3 
and rmSCF grew better than cells cultured with either rrIL-3 
or rmSCF alone, regardless of the Percoll cushion used (Fig. 
6A  and  C).  The  cells  cultured  with  both  rrIL-3  and  rmSCF 
p r o d u c e d  2  t i m e s  m o r e  R M C P  I I  t h a n  t h e  c e l l s  c u l t u r e d  i n 
e i t h e r  r r I L - 3  o r  r m S C F  a l o n e  ( F i g .  6 B  a n d  D ) .
Real time PCR for HDC
Histamine  production  was  used  as  a  measure  of  BMMC 
differentiation.  HDC  expression  was  analyzed  by  real  time 
RT-PCR using 0.006, 0.06 and 0.6μg RNA. An evident dose 
relationship  was  found  between  0.06  and  0.6μg  RNA.  On 
culture day 11 HDC mRNA levels were 500∼800 times higher 
than on culture day 5 (Fig. 7). Fig. 7 showed representative Rat Bone Marrow-derived Mast Cell Induction
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Figure 3. Flowcytometry analysis of cell populations and phenotype 
of cultured rat bone marrow cells. Cell were analyzed by flow 
cytometry for cell size by both FSC and SSC (A), and for surface 
expression of the BC4 (B, C) and AA4 (D, E) antigens. Control with
dotted line in (B∼E) were only treated with the secondary antibody, 
PE-goat anti mouse IgG. The solid lines in (B and C) were for the
membrane protein for the primary antibody, BC4, and the 2nd 
antibody. The solid lines in (D and E) were for the membrane protein
for the primary antibody, AA4, and the 2nd antibody. (B and D) for
gated as the R1, (C and E) gated as the R2.
data.
DISCUSSION
The  proliferation  of  cultured  bone  marrow  cells  peaked  at 
day 8 or day 11 (Fig. 4A∼C). The proliferation kinetics was 
s i m i l a r  t o  t h o s e  d e s c r i b e d  b y  H a i g  et  al  who  found  pro-
liferation  peaked  at  culture  day  6  or  8  (9,38,39).  Although 
rat  BMCs  cultured  in  CM  are  reported  to  proliferate  in  re-
sponse  to  COS-1  cell  supernatant  carrying  recombinant  rat 
IL-3 (19,40), rat BMCs do not proliferate in response to re-
combinant rat IL-3 alone (unpublished data). In contrast, the 
addition  of  rmSCF  and  rrIL-3  induced  evident  BM  cell 
proliferation. Since anti rrSCF antibody inhibits proliferation 
of bone marrow initiated by CM (41,42), SCF is an essential 
f a c t o r  f o r  r a t  B M  c e l l  g r o w t h .
  RMCP II levels were analyzed as a marker for rat mast cells 
(Fig. 4D∼F). Differentiated rat BMMC had high RMCP II lev-
els and thus share characteristics of mucosal mast cells (41). 
RMCP II levels were compared to RMCP I, which is usually 
f o u n d  i n  c o n n e c t i v e  t i s s u e  m a s t  c e l l s  ( 4 3 ) .  R M C P  I I  l e v e l s  
were elevated on culture day 11 in most lysates, indicating 
a  transition  to  a  mucosal  type  mast  cell.
    Histamine is produced mainly by mast cells and basophils. 
This amine imparts its biological activities by binding hista-
mine receptors on the cell membrane of non-classical hista-
mine binding sites, in addition to its itching effect observed 
in allergic reactions (17,32). As an indicator of mast cell matu-
ration,  histamine  levels w e r e  a n a l y z e d  ( F i g .  4 G ∼I).  Hista-
mine levels were specifically elevated in most cases at culture 
day 11. In addition, HDC mRNA levels were more than 500 
times greater on day 11 than on day 5 or 8 (Fig. 7). Although 
cells  were  actively  proliferating  at  day  8,  neither  histamine 
nor mRNA was observed at that point. Since histamine syn-
thesis  and  HDC  transcription  was  much  higher  on  day  11 
than on day 8, mast cell maturation was complete by culture 
day 11. Additionally, histamine production in cultured BMCs 
was  likely  associated  with  new  HDC  transcription  and  not 
with  preformed  HDC,  as  histamine  levels  increased  con-
currently  with  HDC  transcription.
    By  light  microscopy,  the  cells  showed  signs  of  blast  for-
mation, which is indicating of active proliferation (Fig. 1A). 
Upon Toluidine blue staining, the cells harvested days 4, 11 
and 18 had a pink cytoplasm, which is typical of mast cells. 
Cells were observed by electron microscopy, which enhanced 
our  comprehension  of  the  differentiation  process.  Fig.  2A 
s h o w s  B M  c e l l s  w i t h  d i v e r s e  s ize  and  nuclear  structure. 
However, at culture day 4, most cells were relatively homoge-
nous with large nuclei and small black cytoplasmic granules 
(Fig. 2B). On day 11, the nuclei were smaller than on day 
4 (Fig. 2C), while the cytoplasmic granules were bigger. On 
day 15, nuclear structure was not dominant (Fig. 2D). These 
trends  are  similar  to  those  expected  for  mast  cell  differ-
entiation  observed  in  vivo  (22).Rat Bone Marrow-derived Mast Cell Induction
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Figure 4. Cell proliferation, RMCP II production, and histamine synthesis in rat bone marrow cells treated with rrIL-3 and rmSCF. Rat BM cells 
were incubated under specified culture condition. Cells numbers were counted using a hemocytometer (A∼C). RMCP II expression was analyzed
with 200 ng/ml cell lysate of cultured rat bome marrow cells (D∼F). Histamine levels were analyzed using a Histamine EIA kit (G∼I). Culture
conditions were controlled in in terms of serum (FBS vs. HS), media (IMDM vs. RPMI) or percoll concentration (50% vs. 70%). Open/white 
symbol or bar, FBS; and closed/gray symbol or bar, HS. In the line graph: circle, cells separated by 50% percoll; and triangle, cells by 70%
percoll. Solid line, IMDM; and dash-dot line, RPMI-1640.  : 50 IM FBS,  : 50 IM HS,  : 50 RP HS,  : 50 RP HS,  : 
70 IM FBS,  : 70 IM HS,  : 70 RP FBS,  : 70 RP HS. In the bar graph, bar with horizontal line, 50% percoll and IMDM; bar
with oblique line, 50% percoll and RPMI-1640; bar with vertical line, 70% percoll and IMDM; bar with net cross, 70% percoll and RPMI-1640.
: 50 IM FBS,  : 50 IM HS,  : 50 RP FBS,  : 50 RP HS,  : 70 IM FBS,  : 70 IM HS,  : 70 RP FBS,  :
70 RP HS. IM for IMDM, RP for RPMI-1640, NA for not applied, ND for not determined. Y axis for both H and I in log scale.Rat Bone Marrow-derived Mast Cell Induction
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Figure 5. Exocytosis of cultured rat bone marrow cells by IR162 and
B5. Cultled rat bone marrow cells were applied to the processing of
exocytosis by IR162 and B5, a mouse anti rat IgE mAb.
Figure 6. The effects of cytokine 
treatment on rat bone marrow cell 
proliferation and differentiation. The
specified cytokines were added to 
activeted rat bone marrow cells at 
culture day 8, which were incubat-
ed for 3 (black bar) or 7 (white bar) 
days more. At the indicated time 
point, cell proliferation was analy-
zed CCK-8 (A and C) and cell differ-
entiation was analyzed by RMCP II 
production (B and D). Cells harvest-
ed on a 70% Percoll cushion (A and 
B). Cells harvested on a 50% Percoll
cushion. (C and D). rrIL-3, recom-
binant rat interleukin 3; rmSCF, 
recombinant rat stem cell factor; 
RMCP II, rat mast cell protease II; 
rrIL-4, recombinant rat interleukin-4;
rrIL-6, recombinant rat interleukn-6; 
rmIL-3, recombinant mouse inter-
leukin-3; LPS, lipopolysaccharide; 
Con A, concanavalin A. Cell num-
ber is represented as times of the 
given condition described in ma-
terial and methods.
    Based on AA4 staining, mast cells make up only 2.4% of 
non-cultured  rat  BMCs.  Additionally,  the  AA4-positive  cells 
expressed  FcεRI  as  recognized  by  the  BC4  antibody  (22). 
In  this  study,  most  of  the  cultured  rat  bone  marrow  cells 
stained positive for both AA4 and BC4 at culture day 11 (Fig. 
3B∼E). By flow cytometric forward and side scatter analysis, 
2  groups  were  evident  when  plotted  in  the  log  scale  (Fig. 
3A). R1 was 87.7% and R2 was 6.1% of dots. However, the 
R1 was shown as a small pint in the linear scale (unpubli-
shed data). In addition, the R1 was much smaller on day 2 
t h a n  o n  d a y  1 1  ( d a t a  n o t  s h o w n ) .  G i v e n  t h a t  m a t u r e  m a s t  
c e l l s  c o n t a i n  c e l l u l a r  m i c r o g r a n u l e s ,  t h e  R 1  g a t e  m a y  c o n -
stitute material secreted by the mast cells, such as exosomes 
o r  s m a l l  o r g a n e l l e s .
    Mast cells from human cord blood or mouse BM cells are 
affected by certain cytokine or by LPS (44-47). The effect of 
recombinant  cytokines,  LPS,  or  Con-A  on  proliferating  rat Rat Bone Marrow-derived Mast Cell Induction
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Figure 7. Real time RT-PCR assessment of rat histidine decarboxylase
mRNA levels. The ratio was analyzed in log scale on the Y axis. 
Histidine decarboxylase mRNA levels were normalized against the 
house keeping gene GAPDH. Black bar, 0.06μg RNA. White bar, 
0.6μg RNA. Representative data.
bone marrow cells was observed in a CCK-8 test. Bone mar-
row cell proliferation was induced by rrIL-3 and rmSCF and 
needed  a  continuous  supply  of  both  cytokines  for  efficient 
cell  growth.  No  other  tested  cytokine  enhanced  the  pro-
liferation rate (Fig. 6A, C). Mouse IL-3 did not enhance pro-
liferation, even in the presence of mouse SCF. This result is 
consistent to findings by Cohen et al who reported that rat 
IL-3 is differs markedly from mouse IL-3 in amino acid struc-
ture (19). Additionally, neither rrIL-4 nor rrIL-6 induced differ-
e n t i a t i o n  o f  t h e  r a t  m a s t  c e l l s ,  a s  a s s e s s e d  b y  R M C P  I I  
expression.  Continuous  endeavor  was  believed  to  enhance 
rat  mast  cell  differentiation  processing  by  cytokines.
    Although  described  in  the  early  80’s,  generation  of  rat 
BMMCs was not studied or reported after 1999 (10). The rat 
BMMC prepared with resuspended cytokines should simplify 
the  investigation  of  mast  cell  function.  Mouse  BMMCs  are 
generated worldwide from the addition of resuspended cyto-
kine  (5,48,49).  Haig  et  al  showed  that  rat  stem  cell  factor 
alone could induce rat BMC proliferation and differentiation 
into rat BMMC by 1994 (41), although this finding was not 
repeated thereafter.  In addition,  they  recorded  that  the  CM 
used  at  1994  (CM-11994)  did  not  induce  any  rat  BMC 
proliferation. The effect of CM-1994 was contrasted with the 
results reported before 1994 by Haig et al (9,38-40). In con-
trast  to  the  description  by  Haig  et  al,  this  investigation  did 
observe that neither rmSCF nor rrIL-3 alone were not suffi-
c i e n t  t o  i n d u c e  a n y  r a t  B M C  p r o l i f e r a t i o n  w i t h  t h e  a p p l i e d 
method  (data  not  shown).  However,  in  considering  that 
rmSCF  alone  did  not  induce  any  mouse  BMC  proliferation, 
the results of this investigation was regarded to be high prob-
able (50). In addition, rrSCF was shown not to induce mouse 
BMC  proliferation  independently  (51).
    In the preparation of bone marrow derived mast cell, sus-
pending cells are mainly attended in mice, rats and humans 
(9,11,37,46). Rat BMC growing in adherence to culture plate 
bottom  can  be  observed  in  the  culture  only  with  rrIL-3,  in 
which,  any  rapid  proliferation  is  not  observed.  The  inves-
tigation by McCloseky et al described the adhering rat BMC 
as rat BMMC in the culture with both rhSCF and rrIL-3 (10). 
The adhering cells are not appropriate to be compared with 
the  suspending  cells  that  are  rapidly  proliferating.
    Rats are very similar to humans in that both IL-3 and SCF 
are  basically  required  for  mast  cell  differentiation  from  BM 
cells (52,53). Considering the similarity between rats and hu-
mans in the differentiation of mast cells, further studies of rat 
BMMC are regarded to accelerate human diseases related to 
mast  cells.
  The current study described the generation of rat BMMCs 
by  the  simple  addition  of  resuspended  rrIL-3  and  rmSCF. 
Neither the processing of parasite infection and maintenance, 
nor rat IL-3 cDNA transfection is not inevitable processing for 
rat BMMC investigation. In the kinetics of maturation of cul-
tured mast cell, histamine synthesis was elevated abruptly on 
culture day 11, in contrast that RMCP II was progressively in-
creased  (Fig.  4).  When  cell  phenotype  was  analyzed,  cells 
on culture day 8 expressed both FcεRI and ganglioside anti-
gen  for  AA4  (unpublished  data).  In  considering  that  HDC 
mRNA was also abruptly elevated on culture day 11 (Fig. 7), 
rat BMMCs on culture day 8 were regarded to have the char-
acteristics of mucosal mast cells that did not carry any hista-
mine  gene  of  mRNA  or  preformed  histamine.
    This investigation showed that rat bone marrow cells prolif-
erated and differentiated into bone marrow derived mast cell 
i n  t h e  p r e s e n c e  o f  r r I L - 3  a n d  r m S C F .  T h e  p r o l i f e r a t i v e  B M  
cells demonstrate characteristics of mast cells with high levels 
of  histamine  and  RMCP  II.  In  addition,  these  cells  express 
FcεRI and are positive for AA4, which recognizes ganglio-
side.
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